Cell and Gene Therapy Insights

CELL AND GENE THERAPY INSIGHTS

October 2024

Cell and Gene Therapy Insights Vol 10 Issue 9
View Issue

Vol 10 Issue 9

Spotlight: Gene editing

View Spotlight

Vectors focus: Downstream processing 2024

View Focus

Upcoming webinars

Advances in the separation and analysis of AAV-based gene delivery vectors

Advances in the separation and analysis of AAV-based gene delivery vectors

Jukka Kervinen, Yuliya McAnany
21 November
Today
Register
Meeting manufacturing demand: robust scale-up of an AAV suspension process to 1,000L

Meeting manufacturing demand: robust scale-up of an AAV suspension process to 1,000L

Qingrui You, Peiqing Zhang
26 November
in 5
Days
Register
Revolutionizing upstream gene therapy manufacturing with nanofiber microcarriers

Revolutionizing upstream gene therapy manufacturing with nanofiber microcarriers

J Counsell, L Chirica, L Mellby
27 November
in 7
Days
Register
Quality by design in mRNA manufacturing: at-line monitoring coupled with DOE for higher IVT yield and efficiency of purification

Quality by design in mRNA manufacturing: at-line monitoring coupled with DOE for higher IVT yield and efficiency of purification

Rok Sekirnik
3 December
in 13
Days
Register
Enhancing CAR-T efficacy for targeting lymphoma and solid tumors

Enhancing CAR-T efficacy for targeting lymphoma and solid tumors

Ruchi Patel
3 December
in 13
Days
Register
Optimizing lentiviral purification: enhancing chromatography with monoliths

Optimizing lentiviral purification: enhancing chromatography with monoliths

Luka Bevc
4 December
in 14
Days
Register
View all webinars

Latest Articles

Cell therapy analytics: INFOGRAPHIC

Cell therapy analytics: INFOGRAPHIC

22 November
Industrializing cell therapy: how to bring curative therapies to all patients who need them?

Industrializing cell therapy: how to bring curative therapies to all patients who need them?

Jens Vogel
20 November
Overcoming the senescence barrier in stem cell expansion

Overcoming the senescence barrier in stem cell expansion

William Ying Khee Hwang
14 November
Revolutionizing the treatment of cancer with allogeneic CAR-T cell therapy

Revolutionizing the treatment of cancer with allogeneic CAR-T cell therapy

Cokey Nguyen
13 November
Enhancing AAV process quality and efficiency: three case studies highlighting the benefits of upgraded analytics on downstream process development

Enhancing AAV process quality and efficiency: three case studies highlighting the benefits of upgraded analytics on downstream process development

E Hudspeth, I Green, T Dewosky et al.
11 November
Phase-appropriate analytical control of cell therapy manufacture in early development stages

Phase-appropriate analytical control of cell therapy manufacture in early development stages

Vaibhav Patel
11 November
Accelerating gene therapy downstream process development through DoE and scalable chromatography

Accelerating gene therapy downstream process development through DoE and scalable chromatography

Tim Schroeder
7 November
Improving lipid nanoparticle formulations for targeted delivery of genome editors

Improving lipid nanoparticle formulations for targeted delivery of genome editors

Rohit Sharma
5 November
AAV downstream challenges: expert insights

AAV downstream challenges: expert insights

N Clement, W Kish, N Laroudie et al.
4 November

Channel content

Cell therapy analytics: INFOGRAPHIC

Cell therapy analytics: INFOGRAPHIC

22 November
Industrializing cell therapy: how to bring curative therapies to all patients who need them?

Industrializing cell therapy: how to bring curative therapies to all patients who need them?

Jens Vogel
20 November
Enhancing AAV process quality and efficiency: three case studies highlighting the benefits of upgraded analytics on downstream process development

Enhancing AAV process quality and efficiency: three case studies highlighting the benefits of upgraded analytics on downstream process development

E Hudspeth, I Green, T Dewosky et al.
11 November
View channel
Enhancing AAV process quality and efficiency: three case studies highlighting the benefits of upgraded analytics on downstream process development

Enhancing AAV process quality and efficiency: three case studies highlighting the benefits of upgraded analytics on downstream process development

E Hudspeth, I Green, T Dewosky et al.
11 November
Accelerating gene therapy downstream process development through DoE and scalable chromatography

Accelerating gene therapy downstream process development through DoE and scalable chromatography

Tim Schroeder
7 November
AAV downstream challenges: expert insights

AAV downstream challenges: expert insights

N Clement, W Kish, N Laroudie et al.
4 November
View channel
Cell therapy analytics: INFOGRAPHIC

Cell therapy analytics: INFOGRAPHIC

22 November
Enhancing AAV process quality and efficiency: three case studies highlighting the benefits of upgraded analytics on downstream process development

Enhancing AAV process quality and efficiency: three case studies highlighting the benefits of upgraded analytics on downstream process development

E Hudspeth, I Green, T Dewosky et al.
11 November
Phase-appropriate analytical control of cell therapy manufacture in early development stages

Phase-appropriate analytical control of cell therapy manufacture in early development stages

Vaibhav Patel
11 November
View channel
Shifting to non-viral in vivo therapies to enhance global patient access to genetic medicines

Shifting to non-viral in vivo therapies to enhance global patient access to genetic medicines

Hari Pujar
26 September
Navigating the European landscape of advanced therapy funding and commercialization

Navigating the European landscape of advanced therapy funding and commercialization

Dmitry A Kuzmin
2 September
Driving digital innovation for supply chain orchestration in cell and gene therapy

Driving digital innovation for supply chain orchestration in cell and gene therapy

Christian Fuchs
27 August
View channel
Phase-appropriate analytical control of cell therapy manufacture in early development stages

Phase-appropriate analytical control of cell therapy manufacture in early development stages

Vaibhav Patel
11 November
Coming of age: an overview of the growing toolbox for gene editing and its use in CGT applications

Coming of age: an overview of the growing toolbox for gene editing and its use in CGT applications

C Fuentes, J Staudhammer, M Pope et al.
6 October
Beyond CRISPR: exploring the next frontier in gene editing technologies

Beyond CRISPR: exploring the next frontier in gene editing technologies

Devyn Smith
17 September
View channel
Supply chain sourcing and sustainability strategies for cell therapy and advanced biomaterial products

Supply chain sourcing and sustainability strategies for cell therapy and advanced biomaterial products

Raj Joshi
4 November
Trends in innovation for enhanced gene therapy downstream process intensification and product yield

Trends in innovation for enhanced gene therapy downstream process intensification and product yield

Rachel Legmann
28 October
Navigating cold chain complexity to enable clinical-to-commercial transition of advanced therapies

Navigating cold chain complexity to enable clinical-to-commercial transition of advanced therapies

Susan Li
25 September
View channel
Looking to a future of multiplex cell engineering

Looking to a future of multiplex cell engineering

Marco Alessandrini
11 January
Exploring the burgeoning role of non-viral approaches in the delivery of nucleic acids

Exploring the burgeoning role of non-viral approaches in the delivery of nucleic acids

Zhenghong Gao
5 January
Biological & operational considerations for iPSC-derived cell production

Biological & operational considerations for iPSC-derived cell production

A Mogen, A Fernandez-Perez, J Wang et al.
20 December 2023
View channel